These initial resources are being used for laboratory testing, field investigations, surveillance, data analysis, and infection prevention and control.

U.S CDC Commits $3.9 Million  for COVID-19 Activities in Vietnam
The U.S. Centers for Disease Control and Prevention (U.S. CDC) has committed an initial $3.9 million for U.S. CDC’s COVID-19 activities in Vietnam to support prevention, preparedness, and response, including some regional activities. These initial resources are being used for laboratory testing, field investigations, surveillance, data analysis, and infection prevention and control. 
Health cooperation between the United States and Vietnam has been the cornerstone of our bilateral engagement since 1998 when U.S. CDC partnered with Vietnam to establish high-quality, sustainable health systems; strengthen long-term public health capacity; and protect the health of Vietnamese and Americans.  Building on this partnership with U.S. CDC, Vietnam is currently at the forefront of global efforts to prevent, detect, and respond to COVID-19. U.S. CDC has been working with Vietnam to strengthen capabilities in four essential areas:
•Surveillance systems to quickly catch outbreaks before they spread
•Laboratory networks to accurately diagnose disease and identify new pathogens
•Enhance the capacity of frontline health staff to identify, track, and contain outbreaks at their source
•Emergency Operations Centers to coordinate effective response efforts when crises occur.
Since January, U.S. CDC has been supporting Vietnam to prepare for and respond to the COVID-19 pandemic.  This includes: 
•Providing direct technical assistance on emergency operations, specimen transport, laboratory testing , disease surveillance, infection prevention and control (IPC), and risk communication.
•Working alongside Vietnam’s MOH, trained field epidemiologists (disease detectives) conduct outbreak investigations to collect, analyze and interpret data and contribute to evidence-based decisions. 
•Conducting trainings on IPC, contact tracing, and laboratory testing and quality assurance.
•Developing national guidelines and protocols, together with the Ministry of Health in the areas of infection control, health facility readiness and preparedness, surveillance, laboratory testing, and maintaining HIV treatment during COVID-19.  
The goal of U.S. CDC’s global health response to COVID-19 is to limit human-to-human transmission and minimize the global impact of COVID-19 through collaboration with key country and non-governmental partners to mitigate vulnerabilities and gaps in preparedness. $300 million was authorized for U.S. CDC’s global response to COVID-19 as appropriated by Congress in the Coronavirus Preparedness and Response Supplemental Appropriations Act. 
This funding builds on U.S. CDC’s long-standing global investments to control HIV, TB, and malaria, eradicate polio, and prepare for influenza and other pandemic diseases.  U.S. CDC investments to improve health security have laid foundations to rapidly and effectively prepare for emerging threats, including the current coronavirus outbreak.
U.S. CDC’s funding for international COVID-19 preparedness and response is supporting activities in 6 priority technical areas across the globe: Emergency Response; Laboratory, Surveillance and Epidemiology; Border Health; Infection Prevention, Control, and Preparedness in Healthcare Facilities; Pandemic Preparedness Planning; and Vaccine Preparedness. These cross-cutting technical efforts are essential for ending the COVID-19 pandemic globally.